Smartphone Applications for Eating Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Abstract
OBJECTIVE
Given the rising prevalence of eating disorders (EDs), smartphone applications (apps) have received growing clinical attention, but their overall effectiveness remains undetermined. This study aimed to conduct a meta-analysis of randomized controlled trials (RCTs) evaluating the efficacy of app interventions for EDs and to identify the psychological approaches featured in these interventions.
METHOD
The online databases SCOPUS, PubMed, and EBSCO were searched for trials published up to February 2025. This review followed PRISMA guidelines, and meta-analyses were conducted using post-intervention assessment data. Pooled effect sizes were calculated with 95% confidence intervals.
RESULTS
Seventeen studies met the inclusion criteria, and 14 were included in the quantitative synthesis. Trials involving not formally diagnosed samples indicated that app-based interventions were more efficacious than controls in reducing global levels of ED symptomatology, shape and weight concerns, dietary restraint, binge eating, and compensatory behaviors. No significant effects were found for body dissatisfaction/disturbance or drive for thinness. Self-help interventions showed generally comparable improvements. In formally diagnosed samples, only objective binge eating was analyzed, with a medium effect observed when the app was incorporated into guided self-help. The use of an adjunctive app was not shown to have benefit above and beyond traditional therapy. Most interventions were…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.